SCHEMBL25374396

SCHEMBL25374396

NC(=O)CCCCCCCCCCCCC(=O)NCC(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.56
FAAH O00519 8/20 0.54
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
RECQL P46063 2/20 0.47
ALDH1A1 P00352 2/20 0.46
PMP22 Q01453 2/20 0.46
KDM4E B2RXH2 1/20 0.46
USP2 O75604 1/20 0.46
POLB P06746 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
APEX1 P27695 1/20 0.46
BLM P54132 1/20 0.46
GPR18 Q14330 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
SLC6A5 Q9Y345 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25372345 1.00 PTPN1 (0.56) PTPN1FAAHMEN1KMT2ARECQL
SCHEMBL25374908 1.00 PTPN1 (0.56) PTPN1FAAHMEN1KMT2ARECQL
SCHEMBL16384730 0.93 PTPN1 (0.49) PTPN1FAAHMEN1KMT2ARECQL
SCHEMBL30838578 0.91 PTPN1 (0.63) PTPN1FAAHMEN1KMT2ARECQL
SCHEMBL10056657 0.91 PTPN1 (0.63) PTPN1FAAHMEN1KMT2ARECQL
SCHEMBL30838582 0.91 PTPN1 (0.63) PTPN1FAAHMEN1KMT2ARECQL
SCHEMBL8750020 0.91 PTPN1 (0.63) PTPN1FAAHMEN1KMT2ARECQL
SCHEMBL8505361 0.91 PTPN1 (0.63) PTPN1FAAHMEN1KMT2ARECQL
SCHEMBL31336114 0.91 PTPN1 (0.63) PTPN1FAAHMEN1KMT2ARECQL
SCHEMBL2810350 0.91 PTPN1 (0.63) PTPN1FAAHMEN1KMT2ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4238966-B1 TETRAHYDRONAPHTHALENE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF GUANGZHOU HENOVCOM BIOSCIENCE CO LTD (CN) 2026-03-11 EP disclosed
US-12497378-B2 Tetrahydronaphthalene compounds, pharmaceutical compositions, and uses thereof GUANGZHOU HENOVCOM BIOSCIENCE CO., LTD. (CN) 2025-12-16 US disclosed
US-20230391744-A1 TETRAHYDRONAPHTHALENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF GUANGZHOU HENOVCOM BIOSCIENCE CO., LTD. (CN) 2023-12-07 US disclosed
EP-4238966-A1 TETRAHYDRONAPHTHALENE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF Guangzhou Henovcom Bioscience Co. Ltd. (CN) 2023-09-06 EP disclosed
CN-114478476-B Tetrahydronaphthalene compounds, pharmaceutical composition and application thereof 广州市恒诺康医药科技有限公司 2023-06-27 CN disclosed
CN-114478476-A Tetrahydronaphthalenes compounds, pharmaceutical compositions and uses thereof 广州市恒诺康医药科技有限公司 2022-05-13 CN disclosed
WO-2022089408-A1 TETRAHYDRONAPHTHALENE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 广州市恒诺康医药科技有限公司 2022-05-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391744-A1 TETRAHYDRONAPHTHALENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF CYP11B2, HTT, REN PTPN1 1448/4885FAAH 157/4885MEN1 177/4885
US-12497378-B2 Tetrahydronaphthalene compounds, pharmaceutical compositions, and uses thereof CYP11B2, HTT, REN PTPN1 1448/4885FAAH 157/4885MEN1 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.